Novel sensor-integrated proteome on chip (SPOC) platform with thousands of folded proteins on a 1.5 sq-cm biosensor chip to enable high-throughput real-time label-free screening for kinetic analysis

Chidozie Victor Agu,Rebecca L Cook,William Martelly,Lydia R Gushgari,Mukilan Mohan,Bharath Takulapalli

DOI: https://doi.org/10.1101/2024.01.23.575909

2024-01-24

Abstract:An automated proteomic platform for producing and screening an array of functional proteins on biosensor surfaces was developed to address the challenges of measuring proteomic interaction kinetics in high throughput (HTP). This technology is termed Sensor-Integrated Proteome On Chip (SPOC®) which involves cell-free protein expression in nano-liter volume wells (nanowells) directly from rapidly customizable arrays of plasmid DNA, facilitating simultaneous capture-purification of up to 2400 unique full-length folded proteins onto a 1.5 sq-cm surface of a single gold biosensor chip. Arrayed SPOC sensors can then be screened by real-time label-free analysis, including surface plasmon resonance (SPR) to generate kinetic affinity, avidity data. Fluorescent and SPR assays were used to demonstrate zero crosstalk between protein spots. The functionality of the SPOC protein array was validated by antibody binding assay, post-translational modification, mutation-mediated differential binding kinetics, and catalytic activity screening on model SPOC protein arrays containing p53, Src, Jun, Fos, HIST1H3A, and SARS-CoV-2 receptor binding domain (RBD) protein variants of interest, among others. Monoclonal antibodies were found to selectively bind their target proteins on the SPOC array. A commercial anti-RBD antibody was used to demonstrate discriminatory binding to numerous SARS-CoV-2 RBD variants of concern with comprehensive kinetic information. With advantages of HTP, flexibility, low-cost, quick turnaround time, and real-time kinetic affinity profiling, the SPOC proteomic platform addresses the challenges of interrogating protein interactions at scale and can be deployed in various research and clinical applications.

Systems Biology

What problem does this paper attempt to address?

The problem this paper attempts to address is the current limitations of proteomics technologies in high-throughput (HTP) measurement of protein interaction dynamics. Specifically, existing protein microarray technologies are mainly suitable for qualitative and semi-quantitative analysis and cannot provide the required quantitative kinetic data. Additionally, these technologies are often expensive, time-consuming, and difficult to customize on a large scale.

To address these issues, researchers have developed a new platform called Sensor-Integrated Proteome On Chip (SPOC). The SPOC platform achieves high-throughput, real-time, label-free screening, and kinetic analysis by integrating thousands of folded proteins on a 1.5 square centimeter gold biosensor chip. The platform utilizes in situ cell-free expression technology to express proteins directly from a rapidly customizable plasmid DNA array in nanopores and captures and purifies them onto the biosensor chip surface. The SPOC platform not only enables large-scale studies of protein interaction dynamics but also offers advantages such as low cost, quick turnaround time, and high flexibility.

Using techniques such as fluorescence and surface plasmon resonance (SPR), researchers validated the functionality of the SPOC protein array, including antibody binding, post-translational modifications, mutation-mediated binding kinetic differences, and catalytic activity screening. Experimental results indicate that the SPOC platform can effectively detect specific binding of various proteins and generate detailed kinetic data. These features make the SPOC platform widely applicable in various research and clinical applications.